Abstract:Leptin, a cytokine-like protein, plays an important role in the regulation of body weight through inhibition of food intake and stimulation of energy expenditure. Leptin circulates in blood and acts on the brain, which sends downstream signals to regulate body weight. Leptin therapy has been successful in treating leptin deficient obese patients. However, high levels of leptin have been observed in more common forms of obesity indicating a state of leptin resistance which limits the application of leptin in the treatment of obesity. If the central effect of leptin could be by-passed and genes which respond to leptin treatment could be regulated directly, new therapeutic targets for the treatment of obesity may be possible. The purpose of this study was to identify genes and subsequent pathways correlated with leptin-mediated weight loss.WE UTILIZED MICROARRAY TECHNOLOGY TO COMPARE HEPATIC GENE EXPRESSION CHANGES AFTER TWO TYPES OF LEPTIN ADMINISTRATION: one involving a direct stimulatory effect when administered peripherally (subcutaneous: SQ) and another that is indirect, involving a hypothalamic relay that suppresses food intake when leptin is administered centrally (intracerebroventricular: ICV). We identified 214 genes that correlate with leptin mediated weight loss. Several biological processes such as mitochondrial metabolic pathways, lipid metabolic and catabolic processes, lipid biosynthetic processes, carboxylic acid metabolic processes, iron ion binding and glutathione S-transferases were downregulated after leptin administration. In contrast, genes involved in the immune system inflammatory response and lysosomal activity were found to be upregulated. Among the cellular compartments mitochondrion (32 genes), endoplasmic reticulum (22 genes) and vacuole (8 genes) were significantly over represented.In this study we have identified key molecular pathways and downstream genes which respond to leptin treatment and are involved in leptin-mediated weight loss. Many of these genes have previously been shown to be associated with obesity; however, we have also identified a number of other novel target genes. Further investigation will be required to assess the possible use of these genes and their associated protein products as therapeutic targets for the treatment of obesity.

Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice.

Leptin receptor-expressing neuron Sh2b1 supports sympathetic nervous system and protects against obesity and metabolic disease

Hepatic SH2B1 and SH2B2 Regulate Liver Lipid Metabolism and VLDL Secretion in Mice.

Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism.

SH2B1 Defends Against Energy Imbalance, Obesity, and Metabolic Disease via a Paraventricular Hypothalamus→Dorsal Raphe Nucleus Neurocircuit

SH2B1 in β-cells promotes insulin expression and glucose metabolism in mice

Regulation of Insulin and Leptin Signaling by Muscle Suppressor of Cytokine Signaling 3 (SOCS3)

Hepatic Gene Expression Profiling Reveals Key Pathways Involved in Leptin-Mediated Weight Loss in Ob/ob Mice

Lztfl1/BBS17 Controls Energy Homeostasis by Regulating the Leptin Signaling in the Hypothalamic Neurons.

LepRb+ cell–specific deletion of Slug mitigates obesity and nonalcoholic fatty liver disease in mice

A leptin-BDNF pathway regulating sympathetic innervation of adipose tissue

Development of Diabesity in Mice with Neuronal Deletion of Shp2 Tyrosine Phosphatase.

Identification of a GABAergic Neural Circuit Governing Leptin Signaling Deficiency-Induced Obesity

Leptin Signaling is Required for Leucine Deprivation-enhanced Energy Expenditure*

Enhancement of Hypothalamic STAT3 Acetylation by Nuclear Receptor Nur77 Dictates Leptin Sensitivity.

Coordinated Regulation by Shp2 Tyrosine Phosphatase of Signaling Events Controlling Insulin Biosynthesis in Β‐cells

Disrupting Phosphatase SHP2 in Macrophages Protects Mice from High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance by Elevating IL-18 Levels

Sonic Hedgehog Signaling Instigates High-Fat Diet–induced Insulin Resistance by Targeting PPARγ Stability

Modeling Leptin Receptor Insensitivity by Comparing How Leptin or Leptin Receptor Mutations in Mice Affect Body Weight, Basal Metabolism, Body Temperature and Feeding Behaviors

Conditional Knockout of Leptin Receptor in Neural Stem Cells Leads to Obesity in Mice and Affects Neuronal Differentiation in the Hypothalamus Early after Birth

Endothelial Leptin Receptor Mutation Provides Partial Resistance to Diet-Induced Obesity